Hong Kong · Delayed Price · Currency is HKD QingSong Health Statistics
Total Valuation
QingSong Health has a market cap or net worth of HKD 31.00 billion. The enterprise value is 29.94 billion.
| Market Cap | 31.00B |
| Enterprise Value | 29.94B |
Important Dates
The last earnings date was Monday, March 23, 2026.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QingSong Health has 206.37 million shares outstanding. The number of shares has decreased by -17.96% in one year.
| Current Share Class | 206.37M |
| Shares Outstanding | 206.37M |
| Shares Change (YoY) | -17.96% |
| Shares Change (QoQ) | -57.44% |
| Owned by Insiders (%) | 43.02% |
| Owned by Institutions (%) | 1.37% |
| Float | 33.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.18 |
| PB Ratio | 27.79 |
| P/TBV Ratio | 28.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 339.33 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -70.85 |
| EV / Sales | 21.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.36 |
| Quick Ratio | 5.89 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 4.89% |
| Return on Invested Capital (ROIC) | 151.51% |
| Return on Capital Employed (ROCE) | 7.28% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.17M |
| Profits Per Employee | -2.17M |
| Employee Count | 195 |
| Asset Turnover | 1.34 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, QingSong Health has paid 940,325 in taxes.
| Income Tax | 940,325 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 106.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 74.91 |
| Average Volume (20 Days) | 582,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, QingSong Health had revenue of HKD 1.40 billion and -422.56 million in losses. Loss per share was -5.10.
| Revenue | 1.40B |
| Gross Profit | 484.23M |
| Operating Income | 81.82M |
| Pretax Income | -421.62M |
| Net Income | -422.56M |
| EBITDA | 82.34M |
| EBIT | 81.82M |
| Loss Per Share | -5.10 |
Balance Sheet
The company has 1.07 billion in cash and 3.76 million in debt, with a net cash position of 1.06 billion or 5.14 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 3.76M |
| Net Cash | 1.06B |
| Net Cash Per Share | 5.14 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 5.40 |
| Working Capital | 1.09B |
Cash Flow
| Operating Cash Flow | 91.35M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 534,438 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 34.65%, with operating and profit margins of 5.85% and -30.24%.
| Gross Margin | 34.65% |
| Operating Margin | 5.85% |
| Pretax Margin | -30.17% |
| Profit Margin | -30.24% |
| EBITDA Margin | 5.89% |
| EBIT Margin | 5.85% |
| FCF Margin | n/a |
Dividends & Yields
QingSong Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 17.96% |
| Shareholder Yield | 17.96% |
| Earnings Yield | -1.36% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |